NCT02699827View on ClinicalTrials.gov

Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Preeclampsia
Interventions
DRUG

Levobupivacaine hydrochloride

Patients will receive epidural 20 ml levobupivacaine hydrochloride 0.5%

DRUG

Magnesium sulphate

Patients will receive epidural 5 ml magnesium sulphate 10%

DRUG

Saline 0.9%

Patients will receive epidural 5 ml saline 0.9%

Trial Locations (1)

35111

Mansoura University Hospital, Al Mansurah

All Listed Sponsors
lead

Mohamed Sayed Abdelhafez

OTHER

NCT02699827 - Adding MgSO4 to Epidural Levobupivacaine in CS for Patients With Preeclampsia | Biotech Hunter | Biotech Hunter